Friday, December 4, 2009
HER2+ Breast Cancers Recur More Often
Recent studies may give reason for doctors to presribe Herceptin for HER2-positive breast tumors smaller than 6mm.
An RSS feed for the weekly update of relevant headlines from TheBreastCareSite.com